Ethanol Lock Technique: Review of the Literature

被引:69
作者
Maiefski, Melissa [1 ]
Rupp, Mark E. [3 ]
Hermsen, Elizabeth D. [1 ,2 ,3 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pharmaceut & Nutr Care, Nebraska Med Ctr, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pharm Practice, Coll Pharm, Omaha, NE 68198 USA
[3] Univ Nebraska Med Ctr, Infect Dis Sect, Dept Internal Med, Omaha, NE 68198 USA
关键词
CATHETER-RELATED INFECTIONS; BLOOD-STREAM INFECTION; CENTRAL VENOUS CATHETERS; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE PATIENTS; HEMODIALYSIS CATHETERS; INTRAVASCULAR DEVICES; MECHANICAL-PROPERTIES; BACTEREMIA; PREVENTION;
D O I
10.1086/606162
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Central venous catheters (CVCs) are commonly used among adult and pediatric patients for administration of fluids, medications, and nutrition. Central line-associated (CLA) bloodstream infection (BSI) is a serious complication following CVC insertion. The aim of this review is to summarize available data regarding the ethanol lock technique, which is a proposed method for sterilizing the lumen of the catheter by instilling an ethanol solution and allowing it to dwell in the catheter for a certain amount of time. Studies on ethanol lock technique differ in ethanol concentrations, luminal dwell times, catheter types, inclusion of anticoagulants, use of systemic antibiotics, and use of the technique for prevention or for treatment of CLA BSI. In vitro studies demonstrate the efficacy of ethanol in the eradication of various pathogens. Definitive catheter integrity data are limited. Clinical trials report tolerable adverse events with ethanol locks, as well as encouraging results for prevention and treatment of CLA BSI.
引用
收藏
页码:1096 / 1108
页数:13
相关论文
共 47 条
[41]   Comparative in vitro efficacies of various catheter lock solutions [J].
Sherertz, RJ ;
Boger, MS ;
Collins, CA ;
Mason, L ;
Raad, II .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1865-1868
[42]   Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections [J].
Takla, Teresa A. ;
Zelenitsky, Sheryl A. ;
Vercaigne, Lavern M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :1024-1026
[43]   Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies [J].
Tanriover, B ;
Carlton, D ;
Saddekni, S ;
Hamrick, K ;
Oser, R ;
Westfall, AO ;
Allon, M .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2151-2155
[44]   Central vein catheter-related thrombosis in intensive care patients - Incidence, risks factors, and relationship with catheter-related sepsis [J].
Timsit, JF ;
Farkas, JC ;
Boyer, JM ;
Martin, JB ;
Misset, B ;
Renaud, B ;
Carlet, J .
CHEST, 1998, 114 (01) :207-213
[45]   Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital [J].
Warren, David K. ;
Quadir, Wasim W. ;
Hollenbeak, Christopher S. ;
Elward, Alexis M. ;
Cox, Michael J. ;
Fraser, Victoria J. .
CRITICAL CARE MEDICINE, 2006, 34 (08) :2084-2089
[46]   TREATMENT OF CENTRAL VENOUS CATHETER OCCLUSIONS WITH ETHANOL AND HYDROCHLORIC-ACID [J].
WERLIN, SL ;
LAUSTEN, T ;
JESSEN, S ;
TOY, L ;
NORTON, A ;
DALLMAN, L ;
BENDER, J ;
SABILAN, L ;
RUTKOWSKI, D .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1995, 19 (05) :416-418
[47]   The cause of polyurethane catheter cracking during constant infusion of etoposide (VP-16) injection [J].
Yokoyama, H ;
Aoyama, T ;
Matsuyama, T ;
Yamamura, Y ;
Nakajima, K ;
Nakamura, K ;
Sato, H ;
Kotaki, H ;
Chiba, S ;
Hirai, H ;
Yazaki, Y ;
Iga, T .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1998, 118 (12) :581-588